Lumida
/AMRX
⌘K
Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc

AMRX
$17.85USD-1.05%-0.19 today

MARKET CAP

5.7B

P/E (TTM)

19.8x

FWD P/E

16.9x

DAY RANGE

$18 – $18

52W RANGE

$8
$18

AI Summary

Stalk
StalkMedium

AMRX remains in a Stage 2 advance, but the recent blow-off top candle with a long upper wick at key resistance and volume spike signals a potential terminal phase. Price is extended above the 9/21/50 EMA cluster and rejecting, making short‐term timing unfavorable. The medium‐term bias stays bullish in the absence of a breakdown, but execution is deferred: look to engage on a pullback into rising EMA support for trend continuation.

  • Forecasted 20.5% FY earnings growth backed by multiple product approvals.
  • Q1 revenue $720M (+3% YoY), adjusted EBITDA $184M (+13%), EPS $0.45 (+56%).
  • High leverage and 13F outflows indicate institutional skepticism on stability.
Full analysis →
Insider Trades39 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 3, 2026SellAMRXJason B. DalyEVP, Chief Legal Officer185,641$13.31$5.7B-2.94%+132.88%$2.5M-18.98%Stalk
Mar 3, 2026SellAMRXNikita ShahExecutive Vice President255,109$13.31$5.7B-2.94%+132.88%$3.4M-14.37%Stalk
Mar 3, 2026SellAMRXAndrew S BoyerExecutive Vice President275,307$13.31$5.7B-2.94%+132.88%$3.7M-14.61%Stalk
Mar 3, 2026SellAMRXTasos KonidarisExecutive Vice President & CFO306,583$13.31$5.7B-2.94%+132.88%$4.1M-15.73%Stalk
Mar 3, 2026SellAMRXChirag K. PatelPresident & Co-CEO350,978$13.31$5.7B-2.94%+132.88%$4.7M-8.07%Stalk
Mar 3, 2026SellAMRXChintu PatelCo-CEO361,980$13.31$5.7B-2.94%+132.88%$4.8M-8.33%Stalk
Nov 12, 2025SellAMRXNikita ShahExecutive Vice President263,712$7.33$5.7B-2.94%+132.88%$1.9M+0.00%Stalk
Aug 22, 2025SellAMRXNikita ShahExecutive Vice President120,832$9.65$5.7B-2.94%+132.88%$1.2M-28.77%Stalk
Aug 20, 2025SellAMRXAndrew S BoyerExecutive Vice President454,244$6.83$5.7B-2.94%+132.88%$3.1M-13.27%Stalk
Aug 14, 2025SellAMRXNikita ShahExecutive Vice President71,694$9.29$5.7B-2.94%+132.88%$666.0K-21.15%Stalk
Aug 13, 2025SellAMRXTasos KonidarisExecutive Vice President & CFO499,730$9.33$5.7B-2.94%+132.88%$4.7M-35.10%Stalk
Aug 12, 2025SellAMRXJason B. DalyEVP, Chief Legal Officer22,000$9.05$5.7B-2.94%+132.88%$199.1K-67.47%Stalk
Aug 12, 2025SellAMRXAndrew S BoyerExecutive Vice President33,436$9.05$5.7B-2.94%+132.88%$302.6K-11.53%Stalk
Aug 12, 2025SellAMRXNikita ShahExecutive Vice President50,000$9.04$5.7B-2.94%+132.88%$452.0K-12.86%Stalk
May 16, 2025SellAMRXNikita ShahExecutive Vice President49,140$7.58$5.7B-2.94%+132.88%$372.5K-11.22%Stalk
Mar 5, 2025SellAMRXJason B. DalyEVP, Chief Legal Officer90,000$8.80$5.7B-2.94%+132.88%$792.2K-44.52%Stalk
Mar 5, 2025SellAMRXTasos KonidarisExecutive Vice President & CFO100,000$8.91$5.7B-2.94%+132.88%$891.0K-13.85%Stalk
Mar 5, 2025SellAMRXAndrew S BoyerExecutive Vice President125,000$8.89$5.7B-2.94%+132.88%$1.1M-30.11%Stalk
Mar 3, 2025SellAMRXJason B. DalyEVP, Chief Legal Officer64,724$8.78$5.7B-2.94%+132.88%$568.2K-7.65%Stalk
Mar 3, 2025SellAMRXNikita ShahExecutive Vice President134,481$8.77$5.7B-2.94%+132.88%$1.2M-6.15%Stalk
Mar 3, 2025SellAMRXAndrew S BoyerExecutive Vice President145,342$8.77$5.7B-2.94%+132.88%$1.3M-6.87%Stalk
Mar 3, 2025SellAMRXTasos KonidarisExecutive Vice President & CFO155,907$8.77$5.7B-2.94%+132.88%$1.4M-4.58%Stalk
Mar 3, 2025SellAMRXChintu PatelCo-CEO320,835$8.77$5.7B-2.94%+132.88%$2.8M-9.41%Stalk
Mar 3, 2025SellAMRXChirag K. PatelPresident & Co-CEO326,888$8.77$5.7B-2.94%+132.88%$2.9M-9.60%Stalk
Mar 1, 2025SellAMRXNikita ShahExecutive Vice President10,985$8.67$5.7B-2.94%+132.88%$95.2K-3.43%Stalk
Mar 1, 2025SellAMRXAndrew S BoyerExecutive Vice President11,737$8.67$5.7B-2.94%+132.88%$101.8K-4.07%Stalk
Mar 1, 2025SellAMRXTasos KonidarisExecutive Vice President & CFO13,494$8.67$5.7B-2.94%+132.88%$117.0K-2.39%Stalk
Nov 21, 2024SellAMRXJason B. DalySVP, Chief Legal Officer13,665$8.40$5.7B-2.94%+132.88%$114.8K-100.00%Stalk
Nov 15, 2024SellAMRXJason B. DalySVP, Chief Legal Officer43,657$8.61$5.7B-2.94%+132.88%$375.9K-76.16%Stalk
Aug 14, 2024SellAMRXAndrew S BoyerExecutive Vice President62,711$7.84$5.7B-2.94%+132.88%$491.4K-10.18%Stalk
Aug 14, 2024SellAMRXNikita ShahExecutive Vice President100,000$7.75$5.7B-2.94%+132.88%$775.0K-25.53%Stalk
Mar 12, 2024SellAMRXTasos KonidarisExecutive Vice President & CFO30,790$5.31$5.7B-2.94%+132.88%$163.5K-5.52%Stalk
Mar 3, 2024SellAMRXJason B. DalySVP, Chief Legal Officer18,030$5.47$5.7B-2.94%+132.88%$98.6K-2.59%Stalk
Mar 1, 2024SellAMRXTasos KonidarisExecutive Vice President & CFO49,280$5.47$5.7B-2.94%+132.88%$269.6K-2.26%Stalk
Mar 1, 2024SellAMRXNikita ShahExecutive Vice President56,316$5.47$5.7B-2.94%+132.88%$308.0K-3.07%Stalk
Mar 1, 2024SellAMRXAndrew S BoyerExecutive Vice President60,781$5.47$5.7B-2.94%+132.88%$332.5K-3.65%Stalk
Feb 27, 2024SellAMRXAndrew S BoyerExecutive Vice President16,556$5.71$5.7B-2.94%+132.88%$94.5K-5.99%Stalk
Feb 27, 2024SellAMRXNikita ShahExecutive Vice President18,670$5.71$5.7B-2.94%+132.88%$106.6K-5.25%Stalk
Aug 11, 2023SellAMRXAndrew S BoyerExecutive Vice President29,302$4.13$5.7B-2.94%+132.88%$120.9K-10.69%Stalk